Drug recall · October 20, 2021
Glucagon Emergency Kit for Low Blood Sugar recall
Why: SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01
- Lots / codes
Lot #: D239382D, Exp. Date April 2022
- Quantity
- 19,174 syringes
- Company
- Eli Lilly & Company, Indianapolis, IN
- Distribution
- Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico
- Initiated
- September 24, 2021 · Voluntary: Firm initiated
- Classified
- October 14, 2021
- Reported
- October 20, 2021
- Ended
- September 6, 2024
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glucagon
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.